03-31-2023
INR/share | |
Price | 464.70 |
Dividend | 2.51 |
Earnings | 45.12 |
Cash-flow | 30.77 |
Book value | 331.93 |
Equity | 287.39 |
Glenmark Pharmaceuti is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Glenmark Pharmaceuti is a company from India, and his stocks are publicly traded.
Glenmark Pharmaceuti stock dividend
Glenmark Pharmaceuti paid a total dividend of 708 million INR last year, for a market value of 131,045 millions (Market Cap 70,037 millions). Glenmark Pharmaceuti dividend per share is 2.51 INR, and his stock market price 464.70 INR.
According to the chart below, where dividend yield is displayed, Glenmark Pharmaceuti has a dividend yield of 0.54%, lower than the amount offered by both the market average and companies from India. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Glenmark Pharmaceuti stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high India dividend stocks list.
Glenmark Pharmaceuti Dividend Payout
About the ability of Glenmark Pharmaceuti to maintain his current dividend of INR 2.51 per share, an amount that accounts for 0.54%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Glenmark Pharmaceuti payout on ernings is currently 5.56%, which is lower than the market average and companies of Health Care industry, which are 38.61% and 25.33% respectively. Both figures lead us to believe that there is confidence that Glenmark Pharmaceutican maintain his current dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Glenmark Pharmaceuti is INR 30.77 per share, which is higher than the dividend per share paid by the company of INR 2.51, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Glenmark Pharmaceuti, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Glenmark Pharmaceuti Dividend History
Below you will find a table with the historical evolution of Glenmark Pharmaceuti's dividend stock, both in percentage and in INR, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | INR | Paypout | Shares* |
Present | 0.54% | 2.51 | 5.56% | 282 |
2022 | 0.59% | 2.50 | 5.54% | 282 |
2021 | 0.47% | 2.48 | 6.38% | 282 |
2020 | 0.51% | 2.52 | 7.71% | 282 |
2019 | 0.58% | 2.02 | 4.54% | 282 |
2018 | 0.29% | 2.01 | 5.94% | 282 |
2017 | 0.34% | 2.02 | 4.21% | 282 |
2016 | 0.23% | 2.01 | 6.73% | 282 |
2015 | 0.20% | 1.96 | 8.93% | 282 |
*In millions
Then you can see the evolution of Glenmark Pharmaceuti dividend stock, and compare it with the average of India stocks and that of the Pharmaceuticals and Biotechnology stocks.
Glenmark Pharmaceuti Stock performance
Finally, last moth Glenmark Pharmaceuti showed a return of 8.40% compared to a worldwide -0.50% average, and a 1.27% of Health Care firms. Over the last year, the company obtained a 5.10% versus a worldwide performance of a -2.10%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.